Pres, Innovation, Tech Aubrey Rankin sold $790K of Revance Therapeutics, Inc.

Sold$789,888

$23.85Price

33,119Shares

−4%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Mon, Nov 30. Filed Wed, Dec 2, 3:55 PM ET, during the session. Not investment advice.